- ≥99% by HPLC per component; lot-matched COA available
- Lot-matched certificate of analysis
- Ships next business day, tracked
CJC-1295 (No DAC) + GHRP-2
Mod GRF (1-29) paired with the second-generation secretagogue GHRP-2
- FormCo-lyophilized powder, sealed glass vial
- Mol. weightCJC-1295 (No DAC): 3367.93 g/mol · GHRP-2: 817.97 g/mol
- Research areasPulsatile GH release, somatotroph reserve testing, GHS-receptor pharmacology, IGF-1 axis
Supplied for laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
Overview
Pairing it with CJC-1295 without DAC brings a second receptor into the design. That analogue — commonly listed as Modified GRF (1-29) — is a 29-residue GHRH fragment carrying four substitutions that block dipeptidyl peptidase-4 cleavage, and it acts at the GHRH receptor rather than the ghrelin receptor. Because the two receptors sit on the same somatotroph and are regulated differently, co-administration is used to study whether the responses combine additively.
Specifications
Identity
- CAS number
- CJC-1295 (No DAC): 863288-34-0 · GHRP-2: 158861-67-7
- Molecular formula
- CJC-1295 (No DAC): C152H252N44O42 · GHRP-2: C45H55N9O6
- Molecular weight
- CJC-1295 (No DAC): 3367.93 g/mol · GHRP-2: 817.97 g/mol
- Peptide class
- GHRH analogue combined with a second-generation growth hormone-releasing hexapeptide
Supply & purity
- Form
- Co-lyophilized powder, sealed glass vial
- Purity
- ≥99% by HPLC per component; lot-matched COA available
- Available sizes
- 10 mg (5 mg/5 mg)
Additional detail
- Blend ratio
- 1:1 CJC-1295 (No DAC) to GHRP-2
- CJC-1295 sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
- GHRP-2 sequence
- D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
- Also known as
- GHRP-2 is also called pralmorelin or KP-102
- Research areas
- Pulsatile GH release, somatotroph reserve testing, GHS-receptor pharmacology, IGF-1 axis
- Storage
- Lyophilized: −20 °C, protected from light and moisture. Reconstituted: 2–8 °C, use within the study window.
Questions about CJC-1295 (No DAC) + GHRP-2
How does GHRP-2 compare with GHRP-6?
GHRP-2 is the later, more potent hexapeptide of the two and produces substantially less appetite stimulation. GHRP-6 remains preferred where an orexigenic response is the endpoint being studied, while GHRP-2 is chosen when the design calls for growth hormone release with fewer confounding effects.
Is each peptide independently tested?
Yes. Purity is established by HPLC and identity by mass spectrometry for each component at an independent laboratory before the two are co-lyophilized. The certificate of analysis is matched to the lot number printed on your vial and available on request.
What is in the 10 mg (5/5) vial?
Total peptide mass of 10 mg, split evenly — 5 mg of CJC-1295 (No DAC) and 5 mg of GHRP-2, dried together as a single cake. No diluent, syringes or filters are included; bacteriostatic water and reconstitution supplies are listed separately.
Can this blend be used in humans?
No. It is supplied strictly for in-vitro and laboratory animal research by qualified personnel. It is not a drug, supplement or cosmetic in this form, has no approved use as sold, and must not be administered to humans or animals outside an authorised study. We provide no dosing guidance.
Related
